FEPI:NSD-REX FANG & Innovation Equity Premium Income ETF (USD)

ETF | Others |

Last Closing

USD 54.08

Change

+0.18 (+0.33)%

Market Cap

USD 0.06B

Volume

0.05M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-16 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
QQQM Invesco NASDAQ 100 ETF

+0.71 (+0.40%)

USD 22.00B
ACWI iShares MSCI ACWI ETF

+0.47 (+0.44%)

USD 17.94B
IBIT iShares Bitcoin Trust

-0.45 (-1.24%)

USD 17.74B
CGABL The Carlyle Group Inc. 4.625% ..

+0.15 (+0.81%)

USD 16.14B
JEPQ JPMorgan Nasdaq Equity Premium..

+0.22 (+0.42%)

USD 11.73B
TBIL Rbb Fund Inc - Us Treasury 3 M..

N/A

USD 3.07B
IBTE iShares iBonds Dec 2024 Term T..

N/A

USD 2.86B
IBTF iShares iBonds Dec 2025 Term T..

+0.01 (+0.04%)

USD 2.25B
NVDL GraniteShares 1.5x Long NVDA D..

+0.05 (+0.13%)

USD 2.05B
USCL iShares Climate Conscious & Tr..

+0.17 (+0.28%)

USD 2.01B

ETFs Containing FEPI

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.29% 34% F 51% F
Dividend Return 6.45% 98% N/A 99% N/A
Total Return 4.16% 69% C- 69% C-
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.06B 54% F 30% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike